| The effect of pain on cognitive function: a review of clinical and preclinical research O Moriarty, BE McGuire, DP Finn Progress in neurobiology 93 (3), 385-404, 2011 | 1198 | 2011 |
| Stress-induced analgesia RK Butler, DP Finn Progress in neurobiology 88 (3), 184-202, 2009 | 758 | 2009 |
| Stress-induced hyperalgesia EM Jennings, BN Okine, M Roche, DP Finn Progress in neurobiology 121, 1-18, 2014 | 305 | 2014 |
| The cannabinoid system and pain SG Woodhams, V Chapman, DP Finn, AG Hohmann, V Neugebauer Neuropharmacology 124, 105-120, 2017 | 283 | 2017 |
| Psychological stress in early life as a predisposing factor for the development of chronic pain: clinical and preclinical evidence and neurobiological mechanisms NN Burke, DP Finn, BE McGuire, M Roche Journal of neuroscience research 95 (6), 1257-1270, 2017 | 256 | 2017 |
| European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management W Häuser, DP Finn, E Kalso, N Krcevski‐Skvarc, HG Kress, B Morlion, ... European Journal of Pain 22 (9), 1547-1564, 2018 | 221 | 2018 |
| Alterations in the endocannabinoid system in the rat valproic acid model of autism DM Kerr, L Downey, M Conboy, DP Finn, M Roche Behavioural brain research 249, 124-132, 2013 | 187 | 2013 |
| Cannabinoids and pain: sites and mechanisms of action K Starowicz, DP Finn Advances in Pharmacology 80, 437-475, 2017 | 173 | 2017 |
| Minocycline modulates neuropathic pain behaviour and cortical M1–M2 microglial gene expression in a rat model of depression NN Burke, DM Kerr, O Moriarty, DP Finn, M Roche Brain, behavior, and immunity 42, 147-156, 2014 | 163 | 2014 |
| Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials E Fisher, RA Moore, AE Fogarty, DP Finn, NB Finnerup, I Gilron, ... Pain 162, S45-S66, 2021 | 162 | 2021 |
| Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat S Walsh, DP Finn, E Dowd Neuroscience 175, 251-261, 2011 | 158 | 2011 |
| Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats DP Finn, MD Jhaveri, SRG Beckett, CH Roe, DA Kendall, CA Marsden, ... Neuropharmacology 45 (5), 594-604, 2003 | 154 | 2003 |
| Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies DP Finn, S Haroutounian, AG Hohmann, E Krane, N Soliman, ASC Rice Pain 162, S5-S25, 2021 | 140 | 2021 |
| Cognition and pain O Moriarty, DP Finn Current opinion in supportive and palliative care 8 (2), 130-136, 2014 | 123 | 2014 |
| Experimental pain processing in individuals with cognitive impairment: current state of the science R Defrin, M Amanzio, M De Tommaso, V Dimova, S Filipovic, DP Finn, ... Pain 156 (8), 1396-1408, 2015 | 117 | 2015 |
| Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury IL Mohd Isa, SA Abbah, M Kilcoyne, D Sakai, P Dockery, DP Finn, ... Science Advances 4 (4), eaaq0597, 2018 | 111 | 2018 |
| Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease RM Concannon, BN Okine, DP Finn, E Dowd Experimental neurology 269, 133-141, 2015 | 110 | 2015 |
| Cognitive impairment in patients with chronic neuropathic or radicular pain: an interaction of pain and age O Moriarty, N Ruane, D O'Gorman, CH Maharaj, C Mitchell, KM Sarma, ... Frontiers in behavioral neuroscience 11, 100, 2017 | 109 | 2017 |
| Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate K Rea, M Roche, DP Finn British journal of pharmacology 152 (5), 633-648, 2007 | 108 | 2007 |
| The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats M Roche, E O'Connor, C Diskin, DP Finn European Journal of Neuroscience 26 (9), 2643-2653, 2007 | 104 | 2007 |
